Covid 19 vaccine shows promising immune response results
Moderna’s next step will be a 30,000-participant Phase 3 study set to start July 27, which will include South Florida facilities.
CNN’s Dr. Sanjay Gupta reports on the Covid-19 vaccine being developed by the biotechnology company Moderna, in partnership with the National Institutes of Health, that has been found to induce immune responses in all of the volunteers who received it…